Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

AllSci
allsci.com > news > grants > machine-learning-drug-testing-uc-irvine-receives

UC Irvine takes AI-powered metabolic imaging into drug resistance testing

2+ week, 5+ day ago   (399+ words) AllSci University of California, Irvine has received a USD 3 million RC2 grant from the National Center for Advancing Translational Sciences (NCATS) to develop a fluorescence lifetime imaging microscopy (FLIM) and machine learning platform designed to improve how drugs are tested against…...

AllSci
allsci.com > news > licensing-and-partnerships > ai-antibody-discovery-bristol-myers-squibb-taps

Bristol Myers Squibb taps Chai Discovery's generative AI for antibody design across portfolio

3+ week, 2+ day ago   (320+ words) AllSci San Francisco-based Chai Discovery and Bristol Myers Squibb (NYSE: BMY) have announced a collaboration to apply Chai's generative AI antibody discovery platform across BMS's broader portfolio, with the stated goal of building an AI-powered, continuously learning discovery system at…...

AllSci
allsci.com > news > research > ai-antibody-design-specifica-led-benchmark-finds

AI antibody design struggles to beat simple baselines in 29-organization benchmark

3+ week, 3+ day ago   (132+ words) A prospective, blinded competition involving 29 organizations and 511 AI-designed antibody sequences has producedone of the largest prospective, blinded benchmarks of computational antibody design to date — and found that performance varies so widely across groups and tasks that no single algorithmic approach…...